Indian Society of Medical and Paediatric Oncology (ISMPO)—Breast Cancer in Young Guidelines-Reference-Cited by-同舟云学术

Indian Society of Medical and Paediatric Oncology (ISMPO)—Breast Cancer in Young Guidelines

Published:2024-07-22 Issue: Volume: Page:
ISSN:0971-5851
Container-title:Indian Journal of Medical and Paediatric Oncology
language:en
Short-container-title:Indian J Med Paediatr Oncol

Author:

Bajpai Jyoti¹,Gandhi Shruti Sanjay²,Rajappa Senthil³,Pathak Rima⁴^ORCID,Joshi Shalaka⁵,Batra Atul⁶,Singh Manisha⁷,Ghosh Joydeep⁸,Rangarajan Bharath⁹,Prakash Gaurav¹⁰^ORCID,Dubashi Biswajit¹¹^ORCID,Ahmad Syed Nisar¹²,Sreedharan Rinoy¹³,Swamy Mathighatta Shivarudraiah Shivashankara¹⁴,Sirohi Bhawna¹⁵^ORCID,Desai Chirag¹⁶,Chitalkar Prakash¹⁷,Gupta Sudeep¹^ORCID,Malhotra Hemant¹⁸^ORCID,Aggrawal Shyam¹⁹

Affiliation:

1. Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India

2. Department of Medical Oncology, Deenanath Mangeshkar Hospital, Pune, Maharashtra, India

3. Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Banjara Hills, Hyderabad, Telangana, India

4. Department of Radiation Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India

5. Department of Surgical Oncology, Tata Memorial Centre, Parel, Mumbai, Maharashtra, India

6. Department of Medical Oncology, All India Institute of Medical Sciences, Dr. B.R.A. Institute Rotary Cancer Hospital, New Delhi, India

7. Department of Medical Oncology, Mahavir Cancer Sansthan and Research Center, Patna, Bihar, India

8. Department of Medical Oncology, Tata Medical Centre, Kolkata, West Bengal, India

9. Department of Medical Oncology, The Kovai Medical Center and Hospital, Coimbatore, Tamil Nadu, India

10. Department of Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

11. Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

12. Department of Medical Oncology, Sher-e-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India

13. Department of Obstetrics and Gynaecology, Indira IVF Centre, Mumbai, Maharashtra, India

14. Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Center, Delhi, India

15. Department of Medical Oncology, Balco Medical Centre, Vedanta Medical Research Foundation, Raipur, Chhattisgarh, India

16. Department of Medical Oncology, Sterling Hospital, Ahmedabad, Gujrat, India

17. Department of Medical Oncology, Sri Aurobindo Institute of Medical Sciences, Indore, Madhya Pradesh, India

18. Department of Medical Oncology, Sriram Cancer Center, Mahatma Gandhi Medical College Hospital, Jaipur, Rajasthan, India

19. Department of Medical Oncology, Sir Ganga Ram City Hospital, Delhi, India

Abstract

AbstractBreast cancer (BC) is the most common type of cancer globally and in India. In India, BC is more common among younger women compared with Western counterparts. Younger women with BC tend to have a less favorable outcome as they are more likely to have aggressive tumors. Younger women are not well represented in BC management studies as the median age at diagnosis is in the late 50s to early 60s. This can lead to difficulty in using risk-stratification models and molecular tools among young BC patients and may result in overtreatment. Therefore, Indian Society of Medical and Pediatric Oncology gathers and organizes available evidence from published literature to create a guide specifically for young BC patients in low- and middle-income countries like India.

Publisher

Georg Thieme Verlag KG

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0044-1785219.pdf

Reference87 articles.

1. Biology of breast cancer in young women;H A Azim Jr;Breast Cancer Res,2014

2. Unique challenges and outcomes of young women with breast cancers from a tertiary care cancer centre in India;J Bajpai;Breast,2021

3. Young women with breast cancer in Mexico: results of the pilot phase of the Joven &Fuerte prospective cohort;C Villarreal-Garza;JCO Glob Oncol,2020

4. American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility;M E Robson;J Clin Oncol,2015

5. Challenges and opportunities for cancer predisposition cascade screening for hereditary breast and ovarian cancer and lynch syndrome in Switzerland: findings from an international workshop;C Nikolaidis;Public Health Genomics,2018